Influence of Glidescope Assisted Endotracheal Intubation on Intraocular Presure

Effect of Intubation on Intraocular Pressure Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01271621
• Other study ID #: RP 1013
• Status: Completed
• Phase: Phase 4
• Start date: June 2010
• Est. completion date: August 2012

Study information

• Verified date: October 2021
• Source: King Khaled Eye Specialist Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Tracheal intubation with traditional Macintosh laryngoscope is associated with increase in intraocular pressure along with tachycardia and hypertension. These effects are not desirable in ophthalmic patients especially in patients with glaucoma. GlideScope video laryngoscope system is a new approach for laryngoscopy and tracheal intubation. It does not require a direct line of sight to the glottis when intubating with the Glidescope and as a result intubation is much less stimulating to the patient. Therefore GlideScope video laryngoscope assisted intubation could be a preferable technique for intraocular surgery offering advantages in terms of intraocular pressure and cardiovascular stability.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: August 2012
• Est. primary completion date: June 2012
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• ASA physical status 1 or 2 with normal intra-ocular pressure.

Exclusion Criteria:

• history or occurrence of difficult intubation.

• presence of previous anterior segment pathology.

• previous intraocular surgery.

• patients with history of glaucoma.

• brain pathology and other neurological disorder which might affect to their intraocular pressure.

Related Conditions & MeSH terms

• Effect of Intubation on Intraocular Pressure

Intervention

Device:
• Intubation
Endotracheal intubation

Locations

Country	Name	City	State
Saudi Arabia	king Khaled Eye Specialist Hospital	Riyadh

Sponsors (1)

Lead Sponsor	Collaborator
King Khaled Eye Specialist Hospital

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Intraocular pressure		one year